U.S. Clinical Immunoassay Analyzer Market to Exhibit 6.04% CAGR 2016-2020 Owing to Rising Prevalence of Cancers

Published Date : May 30, 2016

ALBANY, NY, May 30, 2016: The U.S. market for clinical immunoassay analyzers has been examined in a market research report recently added to the vast research report portfolio of MarketResearchReports.biz. The report, titled “Clinical Immunoassay Analyzer Market in the US 2016-2020,” states that the market will expand at a favorable 6.04% CAGR from 2016 through 2020. 

Immunoassay analyzers are the instruments used for detecting or measuring specific proteins or other substances in the body through their properties as antibodies or antigens. In clinical laboratories, immunoassay analyzers are used for the detection of cardiac markers, infectious diseases, proteins, endocrine hormones, viral or bacterial infections, etc., from biological samples such as body fluid or blood.

The rising prevalence of a variety of cancers, viral and bacterial infections, and many other diseases has led to a significant rise in research and development into reliable testing equipment on a global front. Technological advancements and the introduction of innovative and highly sophisticated testing equipment in the market have brought about favorable development. The market for disease testing is thus growing at a significant pace.

The high prevalence of a number of cancers in the U.S. has been the major demand driver for the U.S. clinical immunoassay analyzers market in the past years. The market is expected to witness favorable growth over the report’s forecast period as healthcare expenditure in the country continues to rise and the population is highly conscious about personal healthcare.

The report states that the high demand for high-throughput screening with the help of immunoassay analyzers is the major factor driving the U.S. market for clinical immunoassay analyzers. The rising demand for next-generation immunodiagnostic devices to address the complex requirements of clinical laboratories and give reliable, high quality test results is also a significant driver for the U.S. clinical immunoassay analyzers market. Immunoassay analyzers that can improve the workflow of clinical laboratories and reduce turnaround times of tests are also in significant demand in the market.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/717644

On the basis of key application areas of clinical immunoassay analyzers in the U.S., the market has been segmented into oncology and endocrinology, infectious disease testing, GI stool testing, and hepatitis and retrovirus testing. Of these, the segment of oncology and endocrinology is expected to be the fastest-growing application segment in the market over the report’s forecast period. The segment is projected to exhibit a 7% CAGR through 2020.

The report also includes a thorough discussion of the key vendors operating in the U.S. clinical immunoassay analyzer market. The most prominent vendors in the market include Beckman Coulter, Siemens Healthcare Diagnostics, bioMrieux, Roche Diagnostics, DiaSorin, Boditech Med, Affimetrix, Enzo Life Sciences, DRG International, Immunodiagnostics System, Meso Scale Discovery, Nova Century Scientific, SDIX, Inova Diagnostics, EMD Millipore, Randox Laboratories, Radiometer, and Thermo Fisher Scientific.

The market features intense competition among small-, medium-, and large-sized manufacturers of immunoassay analyzers. The formation of partnerships and the introduction of premium-priced products so as to maintain market positions are the major strategies adopted by vendors in the U.S. immunoassay analyzer market.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz